{"name": "Tercica",
 "permalink": "tercica",
 "crunchbase_url": "http://www.crunchbase.com/company/tercica",
 "homepage_url": "http://www.tercica.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "IpsenGroup",
 "category_code": "biotech",
 "number_of_employees": 126,
 "founded_year": 2002,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "650-624-4900",
 "description": "",
 "created_at": "Mon Sep 14 01:39:55 UTC 2009",
 "updated_at": "Sat Apr 06 05:05:19 UTC 2013",
 "overview": "\u003Cp\u003ETercica Inc., a biotechnology company, engages in the development and commercialization of therapeutics for the treatment of endocrine and metabolic diseases. Its products include Increlex, an rDNA origin injection for the long-term treatment of children with short stature due to severe primary IGFD; and Somatuline Depot, a lanreotide injection for the treatment of adults with acromegaly. Tercica Inc. has strategic partnerships with Genentech and Ipsen SA. The company was founded in 2002 and is based in Brisbane, California. As of October 16, 2008, Tercica Inc. operates as a subsidiary of Ipsen S.A.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[80,
       22],
      "assets/images/resized/0005/9639/59639v1-max-150x150.png"],
     [[80,
       22],
      "assets/images/resized/0005/9639/59639v1-max-250x250.png"],
     [[80,
       22],
      "assets/images/resized/0005/9639/59639v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "CEO",
    "person":
     {"first_name": "John",
      "last_name": "A. Scarlett",
      "permalink": "john-a-scarlett",
      "image": null}},
   {"is_past": false,
    "title": " President and COO",
    "person":
     {"first_name": "Richard",
      "last_name": "A. King",
      "permalink": "richard-a-king",
      "image": null}},
   {"is_past": false,
    "title": "",
    "person":
     {"first_name": "Peter",
      "last_name": "Svennilson",
      "permalink": "peter-svennilson",
      "image": null}},
   {"is_past": true,
    "title": "Board Member",
    "person":
     {"first_name": "Karin",
      "last_name": "Eastham",
      "permalink": "karin-eastham",
      "image":
       {"available_sizes":
         [[[109,
            150],
           "assets/images/resized/0026/4129/264129v1-max-150x150.jpg"],
          [[128,
            176],
           "assets/images/resized/0026/4129/264129v1-max-250x250.jpg"],
          [[128,
            176],
           "assets/images/resized/0026/4129/264129v1-max-450x450.jpg"]],
        "attribution": ""}}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$83M",
 "funding_rounds":
  [{"round_code": "unattributed",
    "source_url": "",
    "source_description": "EDGAR",
    "raised_amount": 8000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2007,
    "funded_month": 7,
    "funded_day": 6,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "GenenFUND",
         "permalink": "genenfund",
         "image": null},
       "person": null}]},
   {"round_code": "unattributed",
    "source_url": "http://www.biocentury.com/dailynews/financial/2005-10-14/tercica-gets-75-million-facility",
    "source_description": "Tercica gets $75 million facility",
    "raised_amount": 75000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2005,
    "funded_month": 10,
    "funded_day": 14,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Kingsbridge Capital",
         "permalink": "kingsbridge-capital",
         "image":
          {"available_sizes":
            [[[150,
               23],
              "assets/images/resized/0010/2410/102410v1-max-150x150.jpg"],
             [[250,
               38],
              "assets/images/resized/0010/2410/102410v1-max-250x250.jpg"],
             [[290,
               45],
              "assets/images/resized/0010/2410/102410v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition":
  {"price_amount": 480300000.0,
   "price_currency_code": "USD",
   "term_code": null,
   "source_url": "http://www.lifescience-online.com/Ipsen_to_Acquire_Tercica,10082.html?portalPage=Lifescience+Today.News",
   "source_description": "Ipsen to Acquire Tercica",
   "acquired_year": 2008,
   "acquired_month": 6,
   "acquired_day": 4,
   "acquiring_company":
    {"name": "Ipsen",
     "permalink": "ipsen",
     "image":
      {"available_sizes":
        [[[150,
           48],
          "assets/images/resized/0005/9640/59640v1-max-150x150.png"],
         [[195,
           63],
          "assets/images/resized/0005/9640/59640v1-max-250x250.png"],
         [[195,
           63],
          "assets/images/resized/0005/9640/59640v1-max-450x450.png"]],
       "attribution": null}}},
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "2000 Sierra Point Parkway",
    "address2": "Suite 400",
    "zip_code": "94005",
    "city": "Brisbane",
    "state_code": "CA",
    "country_code": "USA",
    "latitude": 37.674559,
    "longitude": -122.385658}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}